SRE
30
-2
SWN
30
-12
AIV
60
3
NDAQ
48
3
CNP
65
-3
WRK
60
-3
NWS
77
8
VMC
57
3
CME
33
-4
COF
60
-4
GE
65
-2
GME
59
-6
DHR
50
4
O
37
-2
USB
37
4
JPM
60
-2
ABBV
68
-3
PNW
49
4
HBAN
33
2
UNP
50
4
SRE
30
-2
SWN
30
-12
AIV
60
3
NDAQ
48
3
CNP
65
-3
WRK
60
-3
NWS
77
8
VMC
57
3
CME
33
-4
COF
60
-4
GE
65
-2
GME
59
-6
DHR
50
4
O
37
-2
USB
37
4
JPM
60
-2
ABBV
68
-3
PNW
49
4
HBAN
33
2
UNP
50
4
Financhill
Back

Northwest Healthcare Properties Real Estate Investment Trust Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
27

NWH.UN.TO
Northwest Healthcare Properties Real Estate Investment Trust

Last Price:
4.65
Seasonality Move:
0.15%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
27
Northwest Healthcare Properties Real Estate Investment Trust (NWH.UN.TO) is a Sell

Is Northwest Healthcare Properties Real Estate Investment Trust a Buy, Sell or Hold?

  • The current Northwest Healthcare Properties Real Estate Investment Trust [NWH.UN.TO] share price is $4.65. The Score for NWH.UN.TO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NWH.UN.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NWH.UN.TO Stock Price Chart

What is Northwest Healthcare Properties Real Estate Investment Trust's stock price today?

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NWH.UN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 28.51 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.84 - 5.14) Sell
Bollinger Bands (100): (4.4 - 5.1) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

NWH.UN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.8 Sell
20-day SMA: 4.95 Sell
50-day SMA: 5 Sell
200-day SMA: 4.85 Sell
8-day EMA: 4.78 Sell
20-day EMA: 4.9 Sell
50-day EMA: 4.93 Sell
200-day EMA: 5.32 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Northwest Healthcare Properties Real Estate Investment Trust Earnings Growth & NWH.UN.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Northwest Healthcare Properties Real Estate Investment Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):